item management s discussion and analysis of financial condition and results of operations liquidity and capital resources the company s working capital decreased from  at december  to  at december  cash and equivalents decreased  from  at december  to  at december  operating activities provided  in cash flow for the year ended december  inventories increased  from december  the increase in inventory was attributable to the acquisition of dental laboratories 
cash outflows related to dental laboratory acquisitions totaled  for the year ended december  capital expenditures for the same period were  the company expects that increases in capital expenditures  if any  will be in proportion with increasing revenues 
the company maintains a financing agreement the agreement with state street bank and trust company the bank 
the agreement  as amended and extended on june   includes revolving lines of credit of  and  the interest rate on both revolving lines of credit is the prime rate minus one half of one percent or libor rate plus  at the company s option 
both revolving lines of credit mature on june  a commitment fee of one eighth of is payable on the unused amount of both lines of credit 
at december   the full principal amount was available to the company under both revolving lines of credit 
the agreement requires compliance with certain covenants  including the maintenance of specified net worth and other financial ratios 
as of december   the company was in compliance with these covenants 
management believes that existing working capital and financing will be sufficient to meet contemplated operating and capital requirements  including costs associated with anticipated acquisitions  if any  in the foreseeable future 
results of operations the following table sets forth for the periods indicated the percentage of net sales represented by certain items in the company s consolidated financial statements years ended december  net sales cost of goods sold gross profit total operating expenses operating income other income interest income income before provision for income taxes provision for income taxes net income year ended december  compared with year ended december  net sales for the year ended december   net sales increased  or over the prior year ended december  of this increase approximately  or came from same laboratory sales  while approximately  came from acquisitions 
cost of goods sold the company s cost of goods sold  which consists principally of labor and related benefits  cost of materials  and laboratory overhead  increased by  or in the fiscal year ended december  over the prior fiscal year  attributable primarily to increased unit sales 
the company continued its emphasis on training of technical personnel at individual dental laboratories and cross training programs 
cost of goods sold as a percentage of sales for the year remained constant at 
total operating expenses operating expenses  which consist of selling  delivery and administrative expenses both at the laboratory and corporate level  increased by  or in the year ended december  over during this same period operating expenses decreased as a percentage of net sales from in to in operating income due to the increase in net sales and improved productivity  which held constant the cost of goods sold and reduced the operating expenses as a percent of net sales  operating income increased  or in fiscal year over fiscal year interest income interest income decreased by  in the year ended december  from the decrease was due to decreased investment principal following two laboratory acquisitions during the year 
provision for income taxes the provision for income taxes increased to  in from  in this  increase was the result of increased income 
the effective tax rate for fiscal year remained consistent with the effective tax rate for fiscal year net income as a result of all the factors discussed above  net income increased to  or per share on a diluted basis in from  or per share on a diluted basis in year ended december  compared with year ended december  net sales net sales increased  or for the year ended december  over the year ended december  approximately  of this increase was attributable to acquired sales  with the remaining increase representing unit growth at dental laboratories operating throughout the year ended december  and the comparison year ended december  cost of goods sold cost of goods sold  which consists principally of labor and related benefits  cost of materials  and laboratory overhead  increased by  or 
as a percentage of sales  cost of goods sold increased from to  representing a gross margin decrease of 
a portion of the gross margin decrease is attributable to the integration of laboratories acquired in the year ended december  with the company s other laboratories 
total operating expenses total operating expenses  which consist of i selling expenses  the cost of the company s pick up and delivery services and administrative expenses at the dental laboratory level  and ii costs of operation by the company s corporate headquarters and field support services  increased by  or during the year ended december  over this increase was primarily attributable to the operating and amortization expense associated with acquired dental laboratories 
during this same period operating expenses decreased as a percentage of net sales from in to in operating income operating income increased by  or for the year ended december  over the increase was the result of higher sales volume 
operating income was of sales for the years ended december  and interest income interest income decreased by  or in the year ended december  from the decrease was due to lower interest rates for short term liquid investments and decreased investment principal 
provision for income taxes the company s provision for income taxes for the year ended december  increased to  from  in the effective tax rate decreased slightly from to 
net income as a result of the factors discussed above  net income for the year ended december  increased by  or over net income per share on a diluted basis increased from per share to per share 
general this form k and the company s annual report contain forward looking statements within the meaning of section a of the securities act of  as amended  and section e of the securities exchange act of  as amended 
the company s actual results could differ materially from those set forth in the forward looking statements 
certain factors that could affect operating results  capital expenditures  the company s requirements for capital and the costs associated with anticipated acquisitions include general economic conditions  the availability of laboratories for purchase by the company  the ability of the company to acquire and successfully operate additional laboratories  governmental regulation of health care  other factors affecting patient visits to the company s clients  and other risks indicated in the company s filings with the securities and exchange commission 
item a 
quantitative and qualitative disclosures about market risk not applicable 

